Clinical Trials Sponsored by Lung Cancer Alliance

Total 2002 results

Chinese Alliance Against Lung Cancer

Recruiting

Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research (mLOWER)

Solitary Pulmonary Nodule

China
Chinese Alliance Against Lung Cancer

Unknown

Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer (ProLung)

Multiple Pulmonary Nodules | Solitary Pulmonary Nodule

China
Chinese Alliance Against Lung Cancer
Shanghai Respiratory Research Institution

Unknown

The COVID-19 Mobile Health Study (CMHS) (CMHS)

COVID-19

China
Chinese Alliance Against Lung Cancer
LiSen Imprinting Diagnostic Inc.

Unknown

Role of Genomic Imprinting in Cancer Diagnosis

Cancer | Biomarker | Early Diagnosis | Genomic Imprinting

China
Boston Medical Center
Breast Cancer Alliance

Not yet recruiting

Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM)

Breast Cancer Female
New Mexico Cancer Care Alliance
Alliance Healthcare Foundation

Completed

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

Pain | Breast Cancer | Ovarian Neoplasm

United States
Yi-Long Wu

Terminated

Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy (PCI)

Brain Metastases

China
Bai Chunxue
Gene Tech (Shanghai) Company Limited

Unknown

Early Cancer Detection Test - Lung Cancer China (ECLC)

Lung Cancer

China
M.D. Anderson Cancer Center
STRATEGIC ALLIANCE: Merck

Recruiting

A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma

Adenocarcinoma | Tumor

United States
New Mexico Cancer Care Alliance

Recruiting

Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies

Ovarian Cancer

United States
New Mexico Cancer Care Alliance

Recruiting

Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

Oropharyngeal Cancer

United States
New Mexico Cancer Care Alliance

Active, not recruiting

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
New Mexico Cancer Care Alliance

Active, not recruiting

Genome Sequencing of Human Cancer Tissues

Cancer

United States
New Mexico Cancer Care Alliance

Completed

INST 1204: PIK3CA Mutations as Biomarkers for Metastasis in Colon Cancer

Colon Cancer

United States
New Mexico Cancer Care Alliance

Completed

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
New Mexico Cancer Care Alliance

Withdrawn

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Biliary Tract Cancer

United States
New Mexico Cancer Care Alliance

Completed

Combination Paclitaxel, Carboplatin and Temozolomide

Lung Diseases | Cancer

United States
New Mexico Cancer Care Alliance

Completed

Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies

Lung Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

Prostate Cancer

United States
New Mexico Cancer Care Alliance

Completed

The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure

Melanoma

United States
New Mexico Cancer Care Alliance

Terminated

Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
New Mexico Cancer Care Alliance

Terminated

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

Rectal Cancer

United States
New Mexico Cancer Care Alliance

Withdrawn

Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Ovarian Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Comparison of Standard of Care or Treatment on Protocol

Stomach Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Skin Cancer | Uterine Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of Lung

Lung Cancer

United States
New Mexico Cancer Care Alliance

Completed

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Cancer | Kidney

United States
New Mexico Cancer Care Alliance

Withdrawn

A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Chronic Myelogenous Leukemia

United States
New Mexico Cancer Care Alliance

Completed

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Cancer | Leukemia, Other

United States
New Mexico Cancer Care Alliance

Recruiting

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

HER2 Negative Breast Cancer

United States
New Mexico Cancer Care Alliance

Completed

Whole Brain Radiation Using IMRT for Patients With Brain Metastases

Neoplasm Metastasis | Central Nervous System Metastases

United States
New Mexico Cancer Care Alliance

Active, not recruiting

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses

Leukemia, Acute Lymphoblastic

United States
New Mexico Cancer Care Alliance

Completed

Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung

Lung Cancer | Non Small Cell Lung Cancer | Solid Tumors

United States
New Mexico Cancer Care Alliance

Completed

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

Advanced Cancer

United States
New Mexico Cancer Care Alliance

Terminated

IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors

Recurrent Non-small Cell Lung Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach

Cancer | Non-Hodgkin's Lymphoma

United States
New Mexico Cancer Care Alliance

Terminated

Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver

Liver Cancer

United States
New Mexico Cancer Care Alliance

Completed

Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

Sarcoma

United States
New Mexico Cancer Care Alliance

Completed

A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies

Advanced Solid Tumor Malignancies

United States
New Mexico Cancer Care Alliance

Withdrawn

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Prostate Cancer
New Mexico Cancer Care Alliance

Completed

Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter

Liver Cancer

United States
New Mexico Cancer Care Alliance

Completed

A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

Supportive | Ill-defined Sites

United States
New Mexico Cancer Care Alliance

Completed

Clinical Benefit of Topoisomerase Downregulation

Ovarian Cancer

United States
Lung Cancer Mutation Consortium
Lung Cancer Research Foundation

Recruiting

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

NSCLC

United States
New Mexico Cancer Care Alliance

No longer available

Compassionate Use of BYL 719 Alpelisib

Lymphangioma

United States
New Mexico Cancer Care Alliance

Completed

Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography

Breast Cancer Screening

United States
New Mexico Cancer Care Alliance

Terminated

Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (Gem-ox)

Hepatocellular Carcinoma | Bile Duct Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Extrahepatic Bile Duct Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Periampullary Adenocarcinoma

United States
New Mexico Cancer Care Alliance

Terminated

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Melanoma

United States
New Mexico Cancer Care Alliance

Completed

Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States

Clinical Trials Sponsored by Lung Cancer Alliance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations